A simple dilute-and-shoot approach for the determination of ultra-trace levels of arsenic in biological fluids via ICP-MS using CH3F/He as a reaction gas by Flórez, M.R. et al.
 1 
A	 simple	 dilute-and-shoot	 approach	 for	 the	 determination	 of	
ultra-trace	 levels	 of	 arsenic	 in	 biological	 fluids	 via	 ICP-MS	 using	
CH3F/He	as	a	reaction	gas	M.R.	Flórez,a,b	E.	García-Ruiz,a	E.	Bolea-Fernández,b	F.	Vanhaeckeb	and	M.	Resanoa*	
a	University	of	 Zaragoza,	Department	of	Analytical	Chemistry,	Aragón	 Institute	of	Engineering	Research	(I3A),	Pedro	Cerbuna	12,	50009	Zaragoza,	Spain	
b	Ghent	University,	Department	of	Analytical	Chemistry,	Krijgslaan	281-S12,	9000	Ghent,	Belgium		
Abstract	The	 performance	 of	 a	 mixture	 of	 CH3F/He	 (1/9)	 as	 reaction	 gas	 for	 the	determination	of	As	in	biological	fluids	using	a	quadrupole	ICP–MS	instrument	has	been	 explored.	 A	 simple	 (dilute-and-shoot),	 interference-free	 method	 has	 been	developed	to	quantify	As	concentrations	at	trace	and	ultra-trace	levels	in	matrices	with	high	Cl	content.	As+	reacts	with	CH3F	(through	CH3F	addition,	followed	by	HF	elimination)	with	high	efficiency	forming	AsCH2+	as	the	primary	reaction	product,	which	 can	 be	monitored	 at	 a	mass-to-charge	 ratio	 of	 89,	 free	 from	 the	 Cl-based	interferences	 (e.g.,	 40Ar35Cl+	 and	 40Ca35Cl+)	 that	 hamper	 the	monitoring	 of	 75As+.	Matrix	 effects	 are	 overcome	 by	 the	 use	 of	 Te	 as	 an	 internal	 standard	 and	 the	addition	of	3%	v/v	ethanol	to	all	samples	and	calibration	standard	solutions.	The	method	presented	was	validated	by	analysing	a	set	of	reference	materials	(blood,	serum	and	urine)	and	by	assessing	As	recovery	 from	a	set	of	real	blood	samples.	With	 this	 method,	 the	 limit	 of	 detection	 was	 calculated	 to	 be	 0.8	 ng	 L-1	 As,	comparing	 favourably	 with	 the	 vast	 majority	 of	 the	 values	 reported	 in	 the	
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literature,	 even	 with	 those	 obtained	 using	 more	 sophisticated	 sector-field	instrumentation.	
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1.	Introduction	Arsenicosis	or	As	poisoning	 is	most	 commonly	due	 to	 long-term	exposure	 to	As-rich	 drinking	 water.1,2	 The	 World	 Health	 Organization	 (WHO)	 sets	 a	 guideline	value	of	10	µg	L-1	of	As	in	drinking	waters,	but	this	value	is	mainly	governed	by	the	traditional	 limits	 of	 detection	 (LODs).3	 There	 is	 still	 a	 demand	 for	 simple,	 direct	and	 interference-free	methodologies	 that	 allow	 better	 LODs	 to	 be	 obtained	 and,	therefore,	provide	more	reliable	results	 for	 lower	As	concentrations,	 for	 instance	when	 analysing	 biological	 fluids	 as	 a	 proxy	 for	 tracking	 potentially	 elevated	 As	exposure	and	the	related	risks.	Several	 spectroscopic	 techniques	 have	 been	 employed	 for	 As	 determination,	although	 none	 of	 them	 is	 free	 of	 hindrances.4	 Due	 to	 its	 high	 detection	 power,	inductively	coupled	plasma–mass	spectrometry	(ICP–MS)	has	been	widely	used	to	monitor	low	As	contents	in	a	variety	of	samples.	However,	accurate	determination	of	 As	 at	 trace	 and	 ultra-trace	 levels	 by	 ICP–MS	 is	 strongly	 jeopardized	 by	 the	occurrence	of	 spectral	overlap	of	 the	signals	 from	ArCl+	 (40Ar35Cl+,	 38Ar37Cl+)	and	
40Ca35Cl+	ions	with	that	of	the	mono-isotopic	target	element	at	the	mass-to-charge	ratio	(m/z)	of	75.5	This	interference	represents	a	great	challenge	when	aiming	to	determine	As	in	matrices	such	as	blood,	urine	or	serum,	due	to	the	high	amount	of	dissolved	chloride	salts	present	and	the	very	low	As	concentrations	expected.		Several	 analytical	 methodologies	 have	 been	 developed	 to	 overcome	 the	aforementioned	spectral	 interferences,	but	many	of	 them	require	a	separation	of	the	 analyte	 from	 the	matrix	 prior	 to	 the	measurement.	 An	 obvious	 choice	 for	 a	direct	 and	 complete	 resolution	 of	 the	 spectral	 interferences	 would	 be	 using	 a	sector-field	 ICP–MS	 (SF–ICP–MS)	 instrument,	 capable	 of	working	 at	 higher	mass	resolution.6	 However,	 at	 the	 resolution	 required,	 there	 is	 a	 significant	 drop	 in	
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sensitivity,	 which	 is	 not	 desirable	 when	 aiming	 to	 determine	 very	 low	concentrations	of	the	analyte.7	The	use	of	quadrupole-based	ICP–MS	(Q–ICP–MS)	instrumentation	equipped	with	a	collision/reaction	cell	is	a	good	alternative,	especially	as	such	instrumentation	is	more	affordable	to	routine	labs	than	SF–ICP–MS	and,	thus,	it	is	more	widespread.8-
10	 Several	 gases/mixtures	 of	 gases	 have	 been	 explored	 in	 the	 context	 of	 As	determination	 in	 Cl-containing	 matrices,	 in	 an	 attempt	 to	 alleviate	 the	 spectral	interferences.	 Examples	 of	 reactive	 gases	 widely	 used	 and	 documented	 in	 the	literature	 are	 H2,	 O2	 or	 N2O.	 H2	 reacts	 with	 ArCl+	 helping	 in	 reducing	 the	interference	at	m/z	=	75	to	some	extent.11-15	On	the	other	hand,	O2	reacts	with	As+,	forming	the	oxide	ion	75As16O+,	which	can	be	monitored	at	m/z	=	91,	free	from	Cl-based	polyatomic	interferences.16,17	However,	it	has	to	be	kept	in	mind	that	Co	can	form	59Co32O2+,	which	also	shows	a	m/z	=	91.18	It	is	likely	that	this	fact	led	Funk	et	
al.	to	state	that	“quantification	of	As	in	the	DRC	mode	resulted	in	interfering	ions	at	m/z	91”	when	aiming	at	blood	analysis.19	N2O	reacts	with	As+	in	the	same	way	as	O2	does,	as	O-atom	donor.20,21		NH3	could	be	another	possibility.	NH3	reacts	with	40Ar35Cl+	successfully	removing	the	interference,	but	it	also	reacts	with	As+	according	to	what	has	been	described	as	 an	 “unusually	 complex	 condensation	 reaction”	 by	 Baramov	 and	 Tanner,22	leading	to	the	formation	of	various	species,	of	which	As(NH3)NH2+	seems	to	be	the	most	abundant	 ion.	To	 the	best	of	 the	authors’	knowledge,	 the	 formation	of	such	product	has	not	been	used	yet	for	analytical	purposes.		He	 is	 also	 typically	 used	 as	 collision	 gas	 in	 combination	 with	 kinetic	 energy	discrimination	to	reduce	the	contribution	from	polyatomic	interferences,	although	such	approach	 tends	 to	significantly	reduce	 the	sensitivity,	providing	a	signal-to-
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noise	 ratio	 that	 is	 not	 competitive	 with	 those	 obtained	 with	 the	 reactions	described	above.23	Despite	 these	 possibilities,	 As	 determination	 at	 the	 low	 levels	 required	 in	 some	complex	clinical	samples	remains	a	challenge.	A	clear	example	of	these	difficulties	can	be	found	in	a	very	recent	publication,	that	reports	on	As	values	obtained	using	various	approaches,	based	on	collision/reaction	cell	 ICP-MS	and	SF-ICP-MS,	 for	a	new	blood	CRM	material.	The	results	obtained	showed	so	much	scatter	(one	order	of	magnitude	 range)	 that	 the	As	 value	 could	not	 be	 certified	 finally,	 and	only	 an	informative	 <5	 µg	 L-1	 value	 was	 provided	 instead.4	 It	 is	 worthwhile	mentioning	that	the	typical	As	level	in	human	blood	is	precisely	a	few	µg	L-1,	and	thus	clinical	labs	should	be	able	to	routinely	determine	such	levels	reliably.		High	 efficiency	 has	 been	 reported	 for	 the	 reaction	 of	 As+	 with	 CH3F,	 with	predominant	formation	of	AsCH2+	(m/z=89),	upon	CH3F	addition	and	subsequent	elimination	 of	 HF.24	 However,	 this	 reactive	 gas	 has	 been	 tested	 very	 seldom	 in	reaction	 cells.25	Nevertheless,	 very	good	 results	 (both	 in	 terms	of	 sensitivity	 and	LODs)	have	been	obtained	recently	for	As	determination	in	some	biological	CRMs	(tissues	 and	plants)	 using	 a	 tandem	 ICP-mass	 spectrometer	 (ICP-MS/MS),	 a	 new	type	of	ICP-MS	instrumentation	with	a	collision/reaction	cell	situated	in-between	two	quadrupole	units.26	Such	instrumentation	is	more	expensive	than	a	traditional	quadrupole	ICP-MS	unit,	but	enables	a	better	control	of	the	reactions	taking	place	within	 the	 reaction	 cell	 (an	 octopole)	 by	 removing	 all	 ions	with	 a	m/z	 different	from	that	defined	by	the	first	quadrupole,	and	subsequently	selecting	the	desired	m/z	ratio	to	be	monitored	using	the	second	quadrupole.	It	 is	 the	 purpose	 of	 this	 work	 to	 investigate	 the	 potential	 of	 CH3F	 for	 As	determination	 in	 a	 more	 simple	 and	 standard	 (and	 thus,	 more	 widespread)	
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reaction	 cell	 ICP-MS	 instrument.	 Plasma,	 urine	 and,	 especially,	 blood	 have	 been	selected	 as	 target	 samples	 owing	 to	 their	 intrinsic	 interest	 and	 the	 problems	mentioned	 above.	 The	 goal	 of	 the	 work	 was	 to	 develop	 a	 simple,	 but	 accurate	dilute-and-shoot	approach.		
2.	Experimental	
2.1.	Instrumentation	All	 the	 measurements	 were	 carried	 out	 using	 a	 quadrupole-based	 ICP–MS	instrument	 (NexION	 300X),	 which	 is	 commercially	 available	 from	 Perkin	 Elmer	(Waltham,	USA).	This	instrument	is	equipped	with	a	cell	(a	quadrupole)	that	can	be	used	 both	 as	 a	 collision	 cell	 in	 combination	 with	 kinetic	 energy	 discrimination	(KED)	 and	 as	 a	 dynamic	 reaction	 cell	 (DRC).	 The	 instrument	 is	 equipped	with	 a	triple	 cone	 interface,	 with	 an	 additional	 hyper	 skimmer	 cone,	 providing	 a	more	gradual	pressure	reduction	within	the	interface,	which	results	in	less	dispersion	of	the	 ion	beam.	A	quadrupole	 ion	deflector	reflects	 the	 ion	beam	over	a	90	degree	angle,	focusing	it	into	the	cell.	The	 sample	 introduction	 system	 comprises	 a	 0.4	 mL	 min-1	 concentric	 quartz	nebulizer	and	a	quartz	cyclonic	spray	chamber,	with	0.38	mm	inner	diameter	PVC	flared	tubing	for	the	peristaltic	pump.	
2.2.	Samples	and	standards	2.2.1.	Standards	and	reagents	Purified	 water	 was	 obtained	 from	 a	 Milli-Q	 system	 (Millipore,	 Billerica,	 USA).	Moreover,	 high	 purity	 water	 TraceSELECT	 Ultra	 was	 purchased	 from	 Fluka	Analytical	(Sigma-Aldrich,	St.	Louis,	USA).		HNO3	 solutions	 were	 prepared	 from	 14	 mol	 L-1	 HNO3	 SupraPur,	 obtained	 from	Merck	Millipore	(Darmstadt,	Germany),	and	used	for	dilutions.		
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As	 and	 Te	 solutions	 were	 prepared	 from	 commercially	 available	 1	 g	 L-1	 single-element	 standards	 (Merck)	 by	 appropriate	 dilution	 with	 0.14	 mol	 L-1	 HNO3	Suprapur.	Anhydrous,	denatured	ethanol	of	spectrophotometric	purity	grade	(90%	alcoholic	purity)	was	purchased	 from	Alfa	Aesar	 (Karlsruhe,	Germany).	KCl	 solid	salt	(pro	analysis	purity	grade)	was	obtained	from	Merck.	2.2.2.	Samples	Reference	materials	with	different	As	contents	were	analysed	in	order	to	validate	the	method	developed.	Seronorm	trace	elements	in	whole	blood	level	I,	II	and	III,	and	Seronorm	trace	elements	in	serum	level	I,	all	of	them	available	as	lyophilized	materials,	 were	 purchased	 from	 Sero	 AS	 (Billingstad,	 Norway).	 ClinChek	 trace	elements	in	urine	control	level	I	and	II,	also	available	as	lyophilized	materials,	were	purchased	from	Recipe	(Munich,	Germany).	In	addition,	whole	blood	samples	from	healthy	volunteers	were	obtained	from	the	University	Hospital	Miguel	Servet	(Zaragoza,	Spain).	
2.3.	Analytical	method	for	sample	analysis		All	 the	 samples	 and	 reference	 materials	 were	 analysed	 using	 the	 instrumental	settings	and	data	acquisition	settings	listed	in	Table	1.		The	 samples	 were	 not	 treated	 prior	 to	 analysis,	 except	 for	 dilution.	 Different	dilution	 factors	 were	 evaluated	 (25-,	 50-,	 100-	 and	 200-fold),	 but	 the	 final	solutions	always	contained	3%	ethanol	and	1%	HNO3.		A	new	set	of	5	calibration	standard	solutions	of	suitable	concentrations,	adapted	to	the	expected	As	sample	levels	and	also	containing	3%	ethanol	and	1%	HNO3,	was	prepared	for	every	measurement	session.	SupraPur	grade	HNO3	and	TraceSelect	purity	grade	water	were	used	for	dilutions,	in	order	to	assure	low	blank	signals.	
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Te	was	added	as	internal	standard	to	all	sample	and	standard	solutions	for	a	final	concentration	of	20	µg	L-1	Te.		
3.	Results	and	discussion	
3.1.		Study	of	the	reaction	between	As	and	CH3F/He	within	the	reaction	cell	In	 order	 to	 avoid	 the	 major	 interferences	 found	 at	 m/z=75,	 the	 possibility	 to	promote	a	reaction	between	As	and	CH3F	was	investigated.		Zhao	et	al.24	 listed	AsCH2+	 (in	 a	97%	distribution)	 as	 the	primary	product	 of	 the	reaction	between	As	 and	CH3F/He,	with	 a	minor	 (3%)	 formation	of	 the	 addition	product	 As(CH3F)+,	 using	 ICP/selected-ion	 flow	 tube–MS	 (ICP/SIFT–MS).	 Bolea-Fernandez	 et	 al.26	 confirmed	 this	 behaviour	 using	 ICP–MS/MS.	 This	 type	 of	reaction	 with	 CH3F	 (CH3F	 addition	 and	 ulterior	 elimination	 of	 HF)	 is	 not	 very	common.	Fluorination	or	CH3F	addition	are	much	more	usual.	In	fact,	As	is	the	only	element	 listed	 in	ref.	18	 to	undergo	 this	process	as	 the	main	reaction	with	CH3F.	Recently,	it	has	been	shown	that	the	same	is	true	for	Se,	but	in	a	much	less	effective	way.26	 In	any	case,	 this	reaction	between	As	and	CH3F	 is	quite	characteristic	and	has	been	demonstrated	to	be	very	efficient	in	ICP-MS/MS.26		In	 this	 work,	 CH3F/He	 is	 studied	 as	 reaction	 gas	 for	 the	 determination	 of	 As,	making	 use	 of	 a	 more	 conventional	 reaction	 cell–ICP–MS	 instrumentation.	 To	evaluate	 the	 efficiency	 of	 the	 reaction	 and	 the	 products	 generated	 under	 the	reaction	cell	conditions,	a	5	µg	L-1	As	aqueous	standard	solution	was	nebulized	and	measured	at	different	m/z	ratios.	The	reaction	cell	was	pressurized	with	different	CH3F/He	 flow	 rates	 to	 find	 the	 best	 settings	 in	 terms	 of	 sensitivity.	 The	 results,	represented	 in	 Figure	 1,	 show	 an	 evident	 preference	 of	 the	 reaction	 to	 evolve	towards	the	formation	of	AsCH2+,	also	in	the	present	study.		
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As	shown	 in	Figure	1,	 the	maximum	AsCH2+	 signal	 that	 can	be	attained	 is	 lower	than	 the	 initial	 75As+	signal.	The	AsCH2+	signal	 reaches	approx.	40%	of	 the	 initial	
75As+	signal	at	a	flow	of	1.6	mL	min-1	CH3F/He,	and	even	decreases	at	higher	flows.	This	 fact	 is	not	due	 to	poor	reaction	efficiency,	as	 the	remaining	75As+	signal	and	the	 signals	 corresponding	 to	 other	 As	 species	 are	 rather	 low	 at	 such	CH3F/He	flows.	 Instead,	 this	 is	most	 likely	due	 to	 the	presence	of	He,	which,	at	 these	high	flows,	is	expected	to	result	in	scattering	losses.	Nevertheless,	the	addition	of	He	is	highly	 recommended	 for	 this	 type	 of	 reaction	 in	 order	 to	 slow	 down	 the	 ions	sufficiently	 to	 obtain	 a	 good	 reaction	 efficiency.24	 In	 any	 case,	 this	 loss	 of	 raw	sensitivity	 (roughly	 a	 factor	 of	 3)	 seems	 like	 a	 reasonable	 price	 to	 pay	 for	 an	interference-free	detection	of	As,	as	will	be	demonstrated	later	on.		
3.2.		Optimization	of	the	reaction	cell	parameters	A	further	optimization	of	the	reaction	gas	flow	rate	was	carried	out	by	monitoring	the	 signal	 intensity	 of	 AsCH2+	 in	 a	 50-fold	 diluted	 blood	 sample	 at	 different	CH3F/He	 flow	 rates.	 A	 blank	 solution	 containing	 4	 g	 L-1	 Cl	 (the	 concentration	typically	 found	 in	 blood),	 added	 as	 KCl,	 was	 also	measured	 in	 the	 same	way,	 in	order	to	find	the	conditions	providing	the	best	S/N	ratio.	
Figure	2	shows	how	the	signal	intensity	at	m/z	=	89	increases	(left	y-axis)	with	the	reaction	gas	 flow	rate,	 reaching	a	maximum	sensitivity	at	1.6	mL	min-1	CH3F/He.	The	use	of	higher	flow	rates	leads	to	signal	losses,	probably	due	to	scattering.	On	the	other	hand,	the	blank	signal	(right	y-axis)	remains	rather	low	(below	40	cps)	and	 stable	 along	 all	 the	 conditions	 evaluated.	 Therefore,	 an	 optimum	 signal-to-noise	ratio	is	obtained	at	1.6	mL	min-1.	The	rejection	parameter	q	of	the	DRC	(RPq),	associated	with	the	low-mass	cut-off,	was	also	adjusted.	An	RPq	value	of	0.55-0.65	was	found	to	bring	the	best	results	in	
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terms	 of	 LOD.	 A	 summary	 of	 the	 optimized	 instrument	 settings	 is	 presented	 in	
Table	1.	In	 order	 to	 further	 assure	 that	 no	 spectral	 interference	 is	 affecting	 the	measurements	under	these	optimized	conditions,	two	sets	of	0.5,	1,	2.5	and	5	µg	L-1	As	aqueous	 standard	solutions	were	prepared,	 a	 first	one	diluted	with	1%	HNO3	and	a	second	one	diluted	with	1%	HCl.	A	calibration	curve	was	plotted	based	on	the	 results	obtained	 for	each	 set	of	 standard	solutions	 so	 to	 compare	 the	 slopes.	These	 results	 are	 presented	 in	 Figure	 3,	 where	 the	 lack	 of	 any	 significant	difference	 can	 be	 appreciated.	 From	 this	 direct	 comparison,	 it	 can	 be	 concluded	that	the	presence	of	a	high	Cl	content	in	the	matrix	does	not	influence	the	results	when	monitoring	the	AsCH2+	species	at	m/z	=	89,	thus	enabling	the	determination	of	As	free	from	spectral	interference.	
3.3.		Overcoming	non-spectral	interferences	As	 has	 a	 high	 ionization	 potential	 (9.79	 eV),27	 and	 displays	 a	 very	 pronounced	matrix-induced	signal	enhancement	in	some	matrices,	especially	in	the	presence	of	organic	 C	 (C-effect).5,28-35	 Due	 to	 this	 fact,	 some	 strategies	 to	 correct	 for	 matrix	effects	need	to	be	explored.	On	 the	one	hand,	a	 suitable	 internal	 standard	 is	 required,	 in	order	 to	 correct	 for	any	 instrumental	 instability	 or	 signal	 drift	 and	 improve	 the	 precision	 of	 the	measurements.	An	adequate	 internal	 standard	has	 to	be	absent	 from	 the	 sample	matrix,	 should	not	 lead	 to	or	 suffer	 from	spectral	overlap	and	must	have	a	mass	number	 close	 to	 that	 of	 the	 analyte	 and	 a	 similar	 ionization	 potential.36	Additionally,	 in	 this	 case,	 particular	 attention	has	 to	be	paid	not	 to	 introduce	 an	element	 that	will	 react	with	 CH3F/He,	 thus	 creating	 a	 new	 spectral	 interference.	Ge,	 for	 instance,	would	 react	with	 CH3F/He	 via	 F	 atom	 transfer,24	 leading	 to	 the	
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formation	of	70Ge19F+	at	m/z	=	89,	making	the	selection	of	this	element,	often	used	for	 this	 task	 when	 As	 determination	 is	 aimed	 at,	 prohibited	 for	 our	 method.	Overall,	Te	(IP=	9.01	eV)27	seems	to	be	the	best	choice	for	this	work	and	was	used	as	internal	standard	in	all	following	experiments.	On	 the	 other	 hand,	 differences	 in	 the	matrix	 composition	may	 preclude	 a	 direct	quantification	of	As	 in	 the	 samples	based	on	 external	 calibration	versus	 aqueous	standard	 solutions.	 When	 aiming	 to	 determine	 As	 in	 very	 low	 concentrations,	sample	 treatment	 needs	 to	 be	 minimized	 in	 order	 to	 avoid	 analyte	 losses	 or	significant	 external	 contamination.	Moreover,	 depending	 on	 the	 concentration,	 it	might	not	be	possible	to	dilute	the	sample	until	no	matrix	effect	 is	observed.	The	high	 organic	 load	 of	 blood	 and,	 to	 a	 lower	 extent,	 serum	 samples,	 significantly	affects	 the	 plasma	 conditions.	 Even	when	 applying	 internal	 standard	 correction,	such	effect	may	not	be	completely	compensated	for.	Thus,	the	approach	finally	developed	was	based	on	using	a	sufficiently	high	sample	dilution	 factor	 (at	 least	 1:24)	 to	minimize	matrix	 effects	 and,	 also,	 on	 adding	 an	amount	 of	 ethanol	 to	 both	 the	 samples	 and	 the	 standard	 solutions,	 such	 that	basically	its	presence	would	control	the	plasma	conditions,	helping	in	matching	the	potentially	different	behaviour	expected	between	standard	solutions	and	samples.		Moreover,	 it	 is	 well-known	 that	 the	 addition	 of	 an	 appropriate	 amount	 of	 an	organic	compound,	such	as	ethanol,	will	 lead	to	a	more	complete	ionization	of	As	though	the	C-effect,	thus	increasing	the	sensitivity	for	this	element.5,28-35	An	 optimization	 of	 the	 amount	 of	 ethanol	 added	 was	 carried	 out,	 as	 shown	 in	
Figure	4.	As	 can	be	seen	 (Figure	4A),	 the	presence	of	ethanol	 initially	 increases	the	sensitivity,	until	a	value	of	3-5%.	However,	the	LOD	does	not	follow	the	same	trend.	 After	 initially	 dropping,	 the	 LOD	 tends	 to	 increase	 with	 higher	 values,	
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because	 the	blanks	 are	 rising	 even	more	 than	 the	 sensitivity.	A	 value	between	1	and	 3%	 ethanol	 seems	 optimum	 from	 this	 point	 of	 view.	 Even	more	 important,	
Figure	4B	 shows	 that	 overestimated	 results	 are	obtained	 if	 blood	 is	 analysed	 in	the	absence	of	ethanol,	because	the	organic	matrix	tends	to	increase	the	As	signal.	This	 phenomenon	 is	 corrected	 for	 when	 ethanol	 is	 added,	 and	 good	 agreement	with	the	reference	value	is	attained	at	3%	ethanol.	The	same	trend	was	observed	for	 all	 the	 blood	 samples	 tested:	 results	 biased	 15-40%	 high	 (depending	 on	 the	dilution)	 in	 the	 absence	 of	 ethanol,	 and	 values	 in	 agreement	 with	 the	 expected	ones	 when	 samples	 and	 standards	 contained	 3%	 ethanol.	 Thus,	 this	 value	 was	used	in	further	work.		Under	these	conditions,	the	LOD	was	calculated	to	be	0.8	ng	L-1.	A	comparison	with	the	values	found	in	the	literature	for	different	interference-free	As	determination	strategies	is	presented	in	Table	2.	As	can	be	seen,	the	LOD	presented	in	this	work	compares	 favourably	 with	 the	 vast	 majority	 of	 them,	 even	 with	 those	 obtained	using	SF-ICP-MS.	 It	seems	that	only	when	using	CH3F/He	as	reaction	gas	and	the	ICP-MS/MS	 mode	 a	 better	 LOD	 can	 be	 achieved.	 If	 CH3F/He	 is	 used	 in	 a	 triple	quadrupole	instrument	but	the	mass	window	of	the	first	quadrupole	is	maintained	open	 (no	mass	 filtering),	 a	 very	 similar	 LOD	 as	 the	 one	 reported	 in	 the	 current	work	is	obtained.26		It	has	to	be	mentioned	that	the	LODs	presented	in	the	table	are	instrumental	LODs.	Therefore,	any	dilution	required	as	a	consequence	of	sample	pretreatment	needs	to	 be	 factored	 in	 as	 well.	 Thus,	 the	 method	 proposed	 in	 this	 work	 ultimately	provides	 a	 LOD	of	 20	ng	L-1	 and	 a	LOQ	of	 70	ng	L-1	 (for	 a	dilution	 factor	 of	 25).	These	values	are	sufficiently	low	to	determine	As	in	real	blood	samples,	as	will	be	demonstrated	in	the	next	section.		
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3.4.	Method	validation	and	sample	results	In	 order	 to	 validate	 the	 method	 developed,	 all	 the	 reference	 samples	 listed	 in	section	2.2.2.	were	analysed.	All	of	them	were	diluted	in	a	3%	ethanol	solution	to	four	different	dilution	levels:	25-,	50-,	100-	and	200-fold.	As	determination	was	carried	out	according	to	the	optimized	instrumental	settings	listed	in	Table	1.	The	results	obtained	are	presented	in	Table	3.	As	can	be	seen,	for	every	sample,	 the	results	obtained	were	 found	 to	be	 in	good	agreement	with	 the	corresponding	reference	value.	The	confidence	intervals	obtained	for	the	different	dilutions	factors	tested	always	overlapped	among	them	and,	also,	with	the	certified	range.	However,	it	was	also	observed	that	the	values	obtained	with	higher	dilution	factors	tended	to	be	a	bit	lower	(see	1:199	values),	even	if	this	difference	could	not	be	 considered	 as	 statistically	 significant.	 In	 any	 case,	 using	 such	 an	 extreme	dilution	factor	is	not	really	necessary,	and	it	seems	preferable	to	use	intermediate	dilution	 factors	 (1:49	 or	 1:99)	 to	 guarantee	 the	 best	 accuracy,	while	minimizing	residues	in	the	spray	chamber.	It	 is	 worth	 mentioning	 here	 that,	 although	 all	 the	 samples	 and	 standards	 were	diluted	 and	 measured	 under	 the	 same	 conditions,	 urine	 samples	 do	 not	 really	require	 the	 addition	 of	 ethanol,	 as	 no	 significant	matrix	 effect	was	 observed	 for	such	 samples.	 It	 was	 experimentally	 confirmed	 that	 very	 similar	 results	 were	attained	for	urine	when	no	ethanol	was	added.		Finally,	 five	real	blood	samples	were	also	analysed.	Since	no	reference	value	was	available	for	As,	recovery	assays	were	carried	out	by	doping	the	samples	(diluted	1:99)	 with	 a	 0.1	 µg	 L-1	As	 standard	 solution.	 Samples	 were	 measured	 with	 and	without	As	 spike	 and	 the	 results	 thus	 obtained	 are	 presented	 in	Table	4.	 	 In	 all	cases,	recoveries	were	higher	than	90%,	with	an	average	recovery	of	96.8	±	3.9%,	
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further	 proving	 the	 validity	 of	 the	 approach	 proposed	 for	 analysis	 of	 real	 blood	samples.		
4.	Conclusions	This	 work	 presents	 a	 simple	 and	 straightforward	 analytical	 method	 for	 the	interference-free	determination	of	As	at	ultra-trace	levels	in	biological	fluids	with	high	Cl	content	and	a	organic	matrix.	A	1/9	gas	mixture	of	CH3F/He	was	evaluated	as	reaction	gas	in	a	dynamic	reaction	cell	of	a	quadrupole	ICP-MS	instrument.	As	reacts	very	efficiently	and	with	a	high	selectivity	 with	 CH3F/He,	 leading	 to	 the	 formation	 of	 AsCH2+	 as	 the	 primary	product.	Despite	the	strong	matrix	effects	due	to	the	high	organic	load	of	the	samples,	it	was	possible	to	develop	a	simple	“dilute	and	shoot”	approach	by	diluting	the	samples	using	3%	of	ethanol.	This	 simple	method	provides	very	competitive	 limits	of	detection	 (0.8	ng	L-1),	 as	well	as	high	accuracy	and	precision	(typically	better	than	7%	RSD).	
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Table	 1.	 Instrumental	 settings	 and	 data	 acquisition	 parameters	 for	 the	 NexION	300X	Q-ICP-MS	instrument	NexION	300X	 As	determination	Mode	 DRC	Reaction	cell	gas	 CH3F/He	(1/9)	Reaction	cell	gas	flow	rate	 1.6	mL	min-1	Nebulizer	gas	flow	rate	 1.02	L	min-1	Auxiliary	gas	flow	rate	 1.20	L	min-1	Plasma	gas	flow	rate	 18.00	L	min-1	RF	power	 1600	W	RPa	 0.00	RPq	 0.65	Nuclides	monitored	 89AsCH2+,	126Te+	Sweeps/Reading	 100	Readings/Replicate	 1	Replicates	 10	Dwell	time	 20	ms			 	
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Table	2.	Comparison	of	 the	LODs	reported	 in	the	 literature	 for	As	determination	by	means	of	ICP–MS.1	Species	monitored	 System*	(gas)	 LODs/ng	L-1	 Sample	 Publication	As+	 CC	(H2/He)	 147	 Biological	samples	 Ref.	23	As+	 RC	(H2)	 25	 Rain	water	 Ref.	13	As+	 CRI	(H2)	 19-95	 Biological	samples	 Ref.	14	AsO+	 DRC	(O2,	N2O)	 40	 Sea	water	 Ref.	21	AsO+	 DRC	(O2)	 2.0	 Digested	blood	 Ref.	17	As+	 SF–ICP–MS	 10	 Solutions	 Ref.	26	As+	 SF–ICP–MS	 3.0	 Digested	plants	 Ref.	37	AsO+	 MS/MS	(O2)	 1.0	 Digested	plants	 Ref.	38	AsO+	 MS/MS	(O2)	 1.6	 Drinking	water	 Ref.	39	AsO+	 MS/MS	(O2)	 7.0	 Solutions	 Ref.	26	AsCH2+	 MS/MS	(CH3F)	 0.2	 Biological	samples	 Ref.	26	AsCH2+	 MS/MS	(CH3F)	SQ	mode	 1.0	 Biological	samples	 Ref.	26	AsCH2+	 DRC	(CH3F)	 0.8	 Blood,	urine,	serum	 This	work	1LODs	were	 calculated	 as	 3	 times	 the	 standard	 deviation	 of	 the	 blank	 signal	 intensities	divided	by	the	slope	of	the	calibration	curve.		*CC=	 collision	 cell;	 RC:	 reaction	 cell;	 CRI:	 collision	 reaction	 interface;	 DRC=dynamic	reaction	cell;	SF:	sector	field;	SQ:	single	quadrupole.				 	
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Table	3.	Results	obtained	for	As	determination	of	the	biological	certified	reference	materials	mentioned	in	section	2.2.2.	Uncertainty	is	expressed	as	95%	confidence	intervals	(n=4).	
Reference	material	 Reference	value		 Dil.	factor	1:24	 Dil.	factor	1:49	 Dil.	factor	1:99	 Dil.	factor	1:199	Whole		blood,	level	I	/	µg	L-1	 2.4	±	0.5	 3.1	±	0.2	 2.9	±	0.2	 2.9	±	0.2	 2.9	±	0.2	Whole	blood,	level	II	/	µg	L-1	 14.3	±	2.9	 15.3	±	1.1	 14.6	±	1.2	 13.4	±	1.3	 12.6	±	1.7	Whole	blood,	level	III	/	µg	L-1	 30.4	±	7.3	 30.0	±	3.1	 27.1	±	3.1	 26.5	±	3.7	 26.1	±	3.4	Serum,	level	I	/	µg	L-1	 0.40*	 0.45	±	0.07	 0.52	±	0.10	 0.42	±	0.08	 –––	Urine,	level	I	/	µg	L-1	 43.0	±	8.6	 42.9	±	3.4	 43.4	±	3.9	 44.1	±	3.5	 38.8	±	3.6	Urine,	level	II	/	µg	L-1	 83.3	±	16.6	 83.2	±	4.9	 81.2	±	5.8	 78.5	±	5.1	 75.9	±	5.4	*	Indicative	value		
	 	
 21 
Table	4.	Results	obtained	for	As	determination	in	real	blood	samples.	Uncertainty	is	expressed	as	95%	confidence	intervals	(n=4).	Sample	code	 As	content	/	µg	L-1	 Recovery	assay	/	%	MSHBlood01	 5.10	±	0.48	 94.5	MSHBlood02	 5.18	±	0.46	 91.9	MSHBlood03	 3.13	±	0.25	 98.5	MSHBlood04	 2.84	±	0.24	 102.1	MSHBlood05	 14.6	±	1.3	 97.0					 	
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Figure	captions.		
	
Figure	 1.	 Overview	 of	 the	 As-based	 reaction	 products	 generated	 within	 the	dynamic	reaction	cell	at	different	CH3F/He	flow	rates	
Figure	2.	A)	Optimization	of	the	CH3F/He	reaction	gas	flow	rate	for	the	generation	of	AsCH2+(monitored	at	m/z=89)	from	a	1:49	diluted	blood	sample	(left	y-axis)	and	from	an	equivalent	Cl-containing	blank	(right	y-axis).		
Figure	3.	Direct	comparison	of	a	calibration	curve	prepared	by	dilution	with	1%	HNO3	 and	 a	 calibration	 curve	 prepared	 by	 dilution	 with	 1%	 HCl,	 both	 sets	 of	standard	solutions	measured	under	the	conditions	listed	in	Table	1.		
Figure	4.	Optimization	of	the	concentration	of	ethanol	 in	samples	and	standards.	A)	 Variation	 of	 the	 sensitivity	 and	 of	 the	 limit	 of	 detection	 with	 every	 ethanol	concentration	 tested.	 B)	 Results	 obtained	 for	 the	 determination	 of	 As	 in	 a	 1:49	diluted	reference	blood	sample	(the	certified	As	concentration,	30.4	±	7.3	µg	L-1,	is	represented	 by	 a	 red	 line),	 for	 all	 different	 ethanol	 concentrations	 studied.	Uncertainty	is	indicated	as	the	standard	deviation	of	5	replicates.					
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Figure	1.		
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Figure	2.			
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Figure	3.		
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Figure	4.		
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